An interesting case of pulmonary hypertension in nephrotic syndrome due to amphetamine use for attention-deficit hyperactivity disorder.

Khan, Abat; Ubaid, Aamer; Hanif, Muhammad; Jaiswal, Vikash; Gohar, Ashraf; Mehta, Aashna; Ramakrishnan, Dushyant; Shrestha, Abhigan Babu

Khan, Abat; Ubaid, Aamer; Hanif, Muhammad; Jaiswal, Vikash; Gohar, Ashraf; Mehta, Aashna; Ramakrishnan, Dushyant; Shrestha, Abhigan Babu.

Afiliação

Khan A; Departments of Internal Medicine.
Ubaid A; Departments of Internal Medicine.
Hanif M; SUNY Upstate Medical University, New York, NY.
Jaiswal V; AMA School of Medicine, Makati, Philippines.
Gohar A; Respiratory and Critical Care Medicine, University of Missouri Kansas City,Kansas City, MO.
Mehta A; University of Debrecen-Faculty of Medicine, Debrecen, Hungary.
Ramakrishnan D; Respiratory and Critical Care Medicine, University of Missouri Kansas City,Kansas City, MO.
Shrestha AB; M Abdur Rahim Medical College, Dinajpur, Bangladesh.

Ann Med Surg (Lond) ; 85(5): 1874-1877, 2023 May.

Article em En | MEDLINE | ID: mdl-37229094

Palavras-chave

ADHD; amphetamine; end-stage renal disease; minimal change disease; nephrotic syndrome; pulmonary arterial hypertension

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ann Med Surg (Lond) Ano de publicação: 2023 Tipo de documento: Article